CN102199154B - Novel synthesis method for pyrrole derivatives - Google Patents

Novel synthesis method for pyrrole derivatives Download PDF

Info

Publication number
CN102199154B
CN102199154B CN 201110024849 CN201110024849A CN102199154B CN 102199154 B CN102199154 B CN 102199154B CN 201110024849 CN201110024849 CN 201110024849 CN 201110024849 A CN201110024849 A CN 201110024849A CN 102199154 B CN102199154 B CN 102199154B
Authority
CN
China
Prior art keywords
reaction
slowly
solution
room temperature
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110024849
Other languages
Chinese (zh)
Other versions
CN102199154A (en
Inventor
刘兆刚
丛欣
唐锋
黄伟
沈超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIMCERE PHARMACEUTICAL GROUP
Jiangsu Simcere Pharmaceutical Co Ltd
Original Assignee
Jiangsu Simcere Pharmaceutical R&D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Simcere Pharmaceutical R&D Co Ltd filed Critical Jiangsu Simcere Pharmaceutical R&D Co Ltd
Priority to CN 201110024849 priority Critical patent/CN102199154B/en
Publication of CN102199154A publication Critical patent/CN102199154A/en
Application granted granted Critical
Publication of CN102199154B publication Critical patent/CN102199154B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a novel method for high-efficiency preparation of pyrrole 1,2-dicarboxylic acid and derivatives thereof. Pyrrole derivatives are synthesized from inexpensive and easily available 2-pyrrole carboxylic acid ester compound used as a raw material through bromination, decarboxylation and other unit reactions easy and simple to operate.

Description

The new synthetic method of pyrrole derivative
Technical field
The present invention relates to the organic synthesis such as medicine, agricultural chemicals and dyestuff field, be mainly the novel method of the adjacent disubstituted derivatives of a kind of efficient preparation pyrroles.
Background technology
Formula (I)
Suc as formula the important intermediate that is a class in the organic synthesis such as medicine, agricultural chemicals and dyestuff field of the chemical structure shown in (I), for example at Chemical and Pharmaceutical Bulletin, 1997, vol.45, #10, p.1642-1652 mention in, formula (I) compound and the single fluorobenzene that are methyl with R react as NK 1The important method that the receptor antagonist candidate compound is synthetic.
Present published similar compound comprises following compound at least:
Figure BDA0000044937630000012
Due to the special property of electron rich pyrrole ring, make adjacent disubstituted pyrroles compounds especially 2,3-disubstituted pyrroles compound synthetic more difficult, its synthetic method rarely has report at present.
Summary of the invention:
Technical problem to be solved by this invention is to provide the method for a kind of rational synthesis type (I).
Figure BDA0000044937630000013
Formula (I)
Wherein, the R base is selected from methyl, ethyl, propyl group, sec.-propyl, phenyl, halogenophenyl, haloalkyl phenyl, benzyl.Method of the present invention comprises:
A, starting raw material S1 is carried out the dibrominated after saponification at 2,3, decarboxylation forms intermediate S4;
Figure BDA0000044937630000021
B, S4 is carried out R base replace on N, then by with the metal reagent permutoid reaction, pass into CO 2, acidifying obtains S6;
C, the dehydration of adjacent dicarboxylic acid form formula (I) compound.
In above-mentioned reactions steps A, dibrominated can also replace in two iodate, and subsequent step is consistent.
The reaction conditions of above-mentioned reactions steps A is, S1 is dissolved in for example tetracol phenixin of organic solvent under the existence of catalytic amount iodine, then at room temperature slowly drips the carbon tetrachloride solution of bromine, at room temperature stirs after dripping off, and decompression steams solvent, obtains S2; S2 is added 20% NaOH solution, in 60~90 ℃ of reaction 2~6h, then be acidified to pH 2-3 with 6N HCl, treat that a large amount of white solids separate out, filtration final vacuum drying obtains S3; S3 is added appropriate monoethanolamine, in 100 ℃ of heated and stirred 1-3h, be cooled to room temperature after end, add entry, with organic solvent extracted with diethyl ether for example; The extraction liquid washing is dry, and concentrating under reduced pressure is directly used in next step reaction;
Figure BDA0000044937630000022
The reaction conditions of above-mentioned reactions steps B is that S4 solution in 0 ℃, is slowly dropped in the DMF solution of sodium hydride, after stirring 15min, slowly drip BrR, wherein the definition of R base is the same, then rises to room temperature reaction 2-4h, after end, reaction solution is slowly poured in frozen water, and with organic solvent extracted with diethyl ether for example, the organic phase washing is dry, concentrating under reduced pressure uses column chromatography purifying and obtains light yellow liquid S5; S5 is dissolved in organic solvent for example in THF, is cooled to-78 ℃, slowly drip n-BuLi or MAGNESIUM METAL grignard reagent, stir 30min under-78 ℃, pass into CO 2Then gas reaction 1-2.5h slowly rises to room temperature, continues stirring reaction 1-2h.After reaction finishes, reaction solution is slowly poured in frozen water, being acidified to pH with 2N dilute hydrochloric acid is 2 left and right, and with organic solvent ethyl acetate extraction for example, drying after concentrating under reduced pressure, is carried out column chromatography and got the white solid compound s 6;
The reaction conditions of above-mentioned reactions steps C is that with compound s 6 and the dried reflux 3-4h of vinegar, decompression steams vinegar and does, and then can get white solid compound formula (I) by purification by silica gel column chromatography.
The present invention also provides a kind of new intermediate S7, and its structural formula is
Figure BDA0000044937630000031
Beneficial effect of the present invention is:
One, provide a kind of feasible preparation 2, the synthetic route of 3-pyrroles's acid anhydrides, and can be used for further reaction formation 2,3-disubstituted pyrroles compound;
Two, the yield of each step reaction is higher, more than 74%;
Three, provide a kind of alternative new intermediate S7.
Embodiment:
Content of the present invention is further elaborated by following embodiment, but does not limit the scope of the invention.Embodiment: preparation 1-ethyl-3-(4-fluorobenzoyl)-1H-pyrroles-2-carboxylic acid (1)
Figure BDA0000044937630000032
With S1 (2.0g, 14.4mmol) and catalytic amount iodine (3mg) be placed in the single port flask of 100ml, adding the 40ml tetracol phenixin dissolves it, then at room temperature slowly drip bromine (4.6g, 28.8mmol) tetracol phenixin (20ml) solution, at room temperature stir 2h after dripping off, decompression steams the solid crude product of solvent, then purification by silica gel column chromatography (PE/EtOAc=30/1-20/1) obtains 4.05g compound S 2, productive rate 95.0%.
With S2 (2.0g, 6.7mmol) be placed in the single port flask of 100ml, add 20% NaOH solution (20ml), in 85 ℃ of reaction 4h, then be acidified to pH 2-3 with 6N HCl, a large amount of white solids are separated out, and filter final vacuum dry, get 1.78g white solid compound S 3, productive rate 98.3%.
S3 (1g, 3.7mmol) is placed in the single port flask of 50ml, adds the 10ml monoethanolamine, in 100 ℃ of heated and stirred 2h, be cooled to room temperature after end, add 40ml water, with ether (30ml*3) extraction; Ether extraction liquid is used respectively 2N dilute hydrochloric acid, saturated common salt water washing once, then uses anhydrous sodium sulfate drying, and the S4 solution that is evaporated to 20ml is directly used in next step reaction.
With S4 solution in 0 ℃, slowly drop to sodium hydride (297.5mg, 7.4mmol) DMF (10ml) solution in, after stirring 15min, slowly drip monobromethane (806.4g, 7.4mmol), then rise to room temperature reaction 4h, after end, slowly pour into reaction solution in frozen water, with extracted with diethyl ether (30ml*3), then organic phase with the saturated common salt water washing once uses anhydrous sodium sulfate drying, concentrating under reduced pressure, with silicagel column separation and purification (eluent: PE/EtOAc=40/1-30/1) obtain 696.1mg light yellow liquid S5, productive rate 74.0%.
S5 (696.1mg, 2.75mmol) is dissolved in THF (15ml), and solution is placed in the low-temp reaction instrument, is cooled to-78 ℃, slowly drips n-BuLi (1.6M, 3.6ml), stirs 30min under-78 ℃, passes into CO 2Then gas reaction 1.5h slowly rises to room temperature, continues stirring reaction 1h.After reaction finishes, slowly pour into reaction solution in frozen water, being acidified to pH with 2N dilute hydrochloric acid is 2 left and right, use ethyl acetate extraction, anhydrous sodium sulfate drying, after concentrating under reduced pressure, carry out silica gel column chromatography (eluent: PE/EtOAc=5/1-1/1) get 320.2mg white solid compound s 6, productive rate 75.0%.
With compound s 6 (100mg, 0.55mmol) and the dried 50ml single port flask that is placed in of 10ml vinegar, reflux 3-4h, decompression steams vinegar and does, then (eluent: PE/EtOAc=10/1-5/1) purifying can get 85.6mg white solid compound S 7, productive rate 95.0% by silica gel column chromatography.
H-NMR(300MHz,DMSO-d 6):7.92(d,1H),6.25(d,1H),4.36(q,2H),1.36(t,3H)
Compound S 7 (50mg, 0.30mmol) is dissolved in the 3ml fluorobenzene, then slowly drops to anhydrous AlCl 3(60mg, 0.45mmol) and the mixture of fluorobenzene (5ml) in, reflux 3-4h, after end, reaction solution being poured in frozen water, is 2 left and right with the salt acid for adjusting pH of 6N, uses ethyl acetate extraction, anhydrous sodium sulfate drying, concentrating under reduced pressure is with silicagel column separation and purification (eluent: PE/EtOAc=10/1-5/1) obtain 62.5mg compound 1, productive rate 79.1%.
The product that makes is tested, and result is as follows:
1H-NMR(300M,DMSO-d 6)δ12.72(s,1H),7.80(m,2H),7.31(m,2H),7.22(d,1H),6.28(d,1H),4.36(q,2H),1.36(t,3H)。

Claims (8)

1. the method for a synthesis type (I),
Figure FDA00002755198000011
Wherein, the R base is selected from methyl, ethyl, propyl group, sec.-propyl, benzyl, it is characterized in that described method comprises:
A, starting raw material S1 is carried out the dibrominated after saponification at 4,5, decarboxylation forms intermediate S4;
Figure FDA00002755198000012
B, S4 is carried out R base replace on N, then by with the metal reagent permutoid reaction, pass into CO 2, acidifying obtains S6;
Figure FDA00002755198000013
The adjacent dicarboxylic acid dehydration of C, S6 forms formula (I) compound.
2. method according to claim 1, is characterized in that in reactions steps A, dibrominated can replace in two iodate.
3. method according to claim 1, is characterized in that in reactions steps A, S1 being dissolved in tetracol phenixin under the existence of catalytic amount iodine, then at room temperature slowly drip the carbon tetrachloride solution of bromine, at room temperature stir after dripping off, decompression steams solvent, obtains S2
Figure FDA00002755198000014
4. method according to claim 3 is characterized in that S2 is added 20% NaOH solution, in 60 ~ 90 ℃ of reaction 2 ~ 6h, then is acidified to pH2-3 with 6N HCl, treats that a large amount of white solids separate out, and filtration final vacuum drying obtains S3
Figure FDA00002755198000015
5. method according to claim 4, is characterized in that S3 is added monoethanolamine, in 100 ℃ of heated and stirred 1-3h, is cooled to room temperature after end, adds entry, uses extracted with diethyl ether; The extraction liquid washing is dry, and the S4 solution of concentrating under reduced pressure is directly used in next step reaction.
6. method according to claim 1, is characterized in that in reactions steps B, with S4 solution in 0 ℃, slowly drop in the DMF solution of sodium hydride, after stirring 15min, slowly drip BrR, wherein the definition of R base is with claim 1, then rise to room temperature reaction 2-4h, after end, slowly pour into reaction solution in frozen water, use extracted with diethyl ether, the organic phase washing is dry, and concentrating under reduced pressure uses column chromatography purifying and obtains light yellow liquid S5
7. method according to claim 6, is characterized in that S5 is dissolved in THF, is cooled to-78 ℃, slowly drips n-BuLi or MAGNESIUM METAL grignard reagent, stirs 30min under-78 ℃, passes into CO 2Then gas reaction 1-2.5h slowly rises to room temperature, continues stirring reaction 1-2h; Reaction is slowly poured reaction solution in frozen water after finishing, and being acidified to pH with 2N dilute hydrochloric acid is 2 left and right, uses ethyl acetate extraction, and drying after concentrating under reduced pressure, is carried out silica gel column chromatography and got the white solid compound s 6.
8. method according to claim 1, is characterized in that in reactions steps C, and with compound s 6 and aceticanhydride reflux 3-4h, decompression steams aceticanhydride, then can get white solid compound formula (I) by column chromatography purification.
CN 201110024849 2011-01-24 2011-01-24 Novel synthesis method for pyrrole derivatives Active CN102199154B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110024849 CN102199154B (en) 2011-01-24 2011-01-24 Novel synthesis method for pyrrole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110024849 CN102199154B (en) 2011-01-24 2011-01-24 Novel synthesis method for pyrrole derivatives

Publications (2)

Publication Number Publication Date
CN102199154A CN102199154A (en) 2011-09-28
CN102199154B true CN102199154B (en) 2013-06-19

Family

ID=44660171

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110024849 Active CN102199154B (en) 2011-01-24 2011-01-24 Novel synthesis method for pyrrole derivatives

Country Status (1)

Country Link
CN (1) CN102199154B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232461A (en) * 2013-05-21 2013-08-07 苏州科捷生物医药有限公司 Synthesis method of 4-chloroquine anhydride
CN104201009B (en) * 2014-09-03 2017-03-01 齐鲁工业大学 A kind of preparation method of the polymer with nitrogen for electrode material for super capacitor
CN109694343B (en) * 2018-12-19 2020-07-28 帕潘纳(北京)科技有限公司 Decarboxylation method of heterocyclic carboxylic acid compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231785A (en) * 1979-05-21 1980-11-04 Shell Oil Company Herbicide antidotes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231785A (en) * 1979-05-21 1980-11-04 Shell Oil Company Herbicide antidotes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Gribble, Gordon W..Product subclass 14: aryllithium and hetaryllithium compounds.《Science of Synthesis》.2006,(第8a期),357-426.
Potent NK1 Receptor Antagonists: Synthesis and Antagonistic Activity of Various Heterocycles with an N-[3,5-Bis(trifluoromethyl)benzyl]-N-methylcarbamoyl Substituent;Yoshinori IKEURA, et al.;《Chem. Pharm. Bull.》;19971231;第45卷(第10期);1642-1652 *
Product subclass 14: aryllithium and hetaryllithium compounds;Gribble, Gordon W.;《Science of Synthesis》;20061231(第8a期);357-426 *
Yanbing Liu,et al..Generation and reactions of 2,3-dilithio-N-methylindole. Synthesis of 2,3-disubstituted indoles.《Tetrahedron Letters》.Elsevier Science Ltd.,2001,第42卷2949-2951. *
YoshinoriIKEURA et al..Potent NK1 Receptor Antagonists: Synthesis and Antagonistic Activity of Various Heterocycles with an N-[3

Also Published As

Publication number Publication date
CN102199154A (en) 2011-09-28

Similar Documents

Publication Publication Date Title
Dindulkar et al. Supported copper triflate as an efficient catalytic system for the synthesis of highly functionalized 2-naphthol Mannich bases under solvent free condition
RU2540076C2 (en) Method for preparing 1-(2-halogenobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives
CN104530107B (en) A kind of synthetic method of 3-amino-4-fluorobenzoic boric acid
CN102746210A (en) Synthesis method for key intermediate of silodosin
CN109761943B (en) Synthesis method of C-3 alkyl substituted coumarin derivative
CN104557921B (en) The synthetic method of pyrroloquinoline quinone
CN102199154B (en) Novel synthesis method for pyrrole derivatives
CN101475451B (en) Method for synthesizing trans-resveratrol
WO2022142159A1 (en) Preparation method for icetexane type abietane diterpene
Yadav et al. FeCl3-catalyzed alkylation of indoles with 1, 3-dicarbonyl compounds: an expedient synthesis of 3-substituted indoles
CN105646285B (en) One kind dimension Lactel sieve intermediate and its preparation method and application
CN104130188A (en) Preparation method of 8-chloro-1-methyl-2,3,4,5- tetrahydro -1H-3-benzoazatropylidene
Zhao et al. Copper-catalyzed decarboxylative hydroboration of phenylpropiolic acids under ligand-free or both ligand-and base-free conditions
JP2010030991A (en) Method for producing 3-methyl-2-thiophenecarboxylic acid
CN113651788B (en) 3-aminoalkylchromone compound and preparation method thereof
CN102336699B (en) Chiral compound
CN102603571B (en) Preparation method of 2,4-dichloro-3-cyano-5-fluobenzoic acid
CN109553633A (en) A kind of preparation method of phenylacetic acid type aryne
CN104402795A (en) Synthetic method of substituted indol-2-formic acid
CN104311432B (en) ADZ6140 important intermediate (1R, 2S)-2-(3,4-difluoro-benzene base) preparation method of cyclopropylamine
CN109020895B (en) Synthesis method of metal-catalyzed 1-benzylamino-substituted benzimidazole
CN108276268B (en) Preparation method of 1, 3-diaryl propine ketone
CN101747271B (en) Method for preparing polysubstituted isoquinoline compounds
CN102010323B (en) Method for synthesizing ibuprofen and analogues thereof
CN102086147B (en) Preparation method of substituted phenol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18

Applicant after: Jiangsu Simcere Pharmaceutical Research Company Limited

Address before: 210042 -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, 669

Applicant before: Jiangsu Simcere Pharmaceutical Research Company Limited

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.

Effective date: 20150331

Owner name: NANJING SIMCERE DONGYUAN PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: JIANGSU SIMCERE PHARMACEUTICAL RESEARCH COMPANY LIMITED

Effective date: 20150331

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 210042 NANJING, JIANGSU PROVINCE TO: 211800 NANJING, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150331

Address after: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Jiangsu, Nanjing

Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.

Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd.

Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18

Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited

CP03 Change of name, title or address

Address after: No.99, Huakang Road, Jiangbei new district, Nanjing, Jiangsu Province, 210032

Patentee after: SIMCERE PHARMACEUTICAL Group

Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd.

Address before: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Jiangsu, Nanjing

Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd.

Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd.

CP03 Change of name, title or address